This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIERBAUM, B. E.
Right arrow Articles by WELCH, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIERBAUM, B. E.
Right arrow Articles by WELCH, R. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery 81:2-10 (1999)
© 1999 The Journal of Bone and Joint Surgery, Inc.

An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty*

BENJAMIN E. BIERBAUM, M.D.{dagger}, CHESTNUT HILL, MASSACHUSETTS, JOHN J. CALLAGHAN, M.D.{ddagger}, IOWA CITY, IOWA, JORGE O. GALANTE, M.D., D.M.SC.§, CHICAGO, ILLINOIS, HARRY E. RUBASH, M.D.#, BOSTON, MASSACHUSETTS, ROBERT E. TOOMS, M.D.**, MEMPHIS, TENNESSEE and RICHARD B. WELCH, M.D.{dagger}{dagger}, SAN FRANCISCO, CALIFORNIA

Three hundred and thirty orthopaedic surgeons in the United States participated in a study of transfusion requirements associated with total joint arthroplasty. A total of 9482 patients (3920 patients who had a total hip replacement and 5562 patients who had a total knee replacement) were evaluated prospectively from September 1996 through June 1997. Of those patients, 4409 (46 percent [57 percent of the patients who had a hip replacement and 39 percent of the patients who had a knee replacement]) had a blood transfusion. Two thousand eight hundred and ninety patients (66 percent) received autologous blood, and 1519 patients (34 percent) received allogenic blood. Ordered logistic regression analysis showed the most important predictors of the transfusion of allogenic blood to be a low baseline hemoglobin level and a lack of predonated autologous blood. Preoperative donation of autologous blood decreases the risk of transfusion of allogenic blood; however, inefficiencies in the procedures for obtaining autologous blood were identified. Sixty-one percent (5741) of the patients had predonated blood for autologous transfusion, but 4464 (45 percent) of the 9920 units of the predonated autologous blood were not used. Primary procedures and revision total knee arthroplasty were associated with the greatest number of wasted autologous units. Of the 5741 patients who had predonated blood, 503 (9 percent) needed a transfusion of allogenic blood. The frequency of allogenic blood transfusion varied with respect to the type of operative procedure (revision total hip arthroplasty and bilateral total knee arthroplasty were associated with the highest prevalence of such transfusions) and with a baseline hemoglobin level of 130 grams per liter or less. Transfusion of allogenic blood was also associated with infection (p <= 0.001), fluid overload (p <= 0.001), and increased duration of hospitalization (p <= 0.01). These latter findings warrant further evaluation in controlled studies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
R. S. Weber, N. Jabbour, and R. C. G. Martin II
Anemia and Transfusions in Patients Undergoing Surgery for Cancer
Ann. Surg. Oncol., January 1, 2008; 15(1): 34 - 45.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
C. Restrepo, J. Parvizi, T. Dietrich, and T. A. Einhorn
Safety of Simultaneous Bilateral Total Knee Arthroplasty. A Meta-Analysis
J. Bone Joint Surg. Am., June 1, 2007; 89(6): 1220 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
R. J. DeBellis
Anemia in critical care patients: Incidence, etiology, impact, management, and use of treatment guidelines and protocols
Am. J. Health Syst. Pharm., February 1, 2007; 64(3_Supplement_2): S14 - S21.
[Abstract] [Full Text] [PDF]


Home page
ASH-SAPHome page
J. M. Shammo and F. M. Stewart
Hematopoietic growth factors
ASH Self-Assessment Program, January 1, 2007; 2007(1): 45 - 60.
[Full Text] [PDF]


Home page
JBJSHome page
P. J. Millett, M. Porramatikul, N. Chen, D. Zurakowski, and J. J.P. Warner
Analysis of Transfusion Predictors in Shoulder Arthroplasty
J. Bone Joint Surg. Am., June 1, 2006; 88(6): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
N. Tsumara, S. Yoshiya, T. Chin, R. Shiba, K. Kohso, and M. Doita
A prospective comparison of clamping the drain or post-operative salvage of blood in reducing blood loss after total knee arthroplasty
J Bone Joint Surg Br, January 1, 2006; 88-B(1): 49 - 53.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. T. Goodnough, A. Shander, J. L. Spivak, J. H. Waters, A. J. Friedman, J. L. Carson, E. M. Keating, T. Maddox, and R. Spence
Detection, Evaluation, and Management of Anemia in the Elective Surgical Patient
Anesth. Analg., December 1, 2005; 101(6): 1858 - 1861.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
Y. Kalairajah, D. Simpson, A. J. Cossey, G. M. Verrall, and A. J. Spriggins
Blood loss after total knee replacement: EFFECTS OF COMPUTER-ASSISTED SURGERY
J Bone Joint Surg Br, November 1, 2005; 87-B(11): 1480 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
P. J. Walmsley, M. B. Kelly, R. M. F. Hill, and I. Brenkel
A prospective, randomised, controlled trial of the use of drains in total hip arthroplasty
J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1397 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. Madjdpour and D. R. Spahn
Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications
Br. J. Anaesth., July 1, 2005; 95(1): 33 - 42.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. W. G. Weber, R. Slappendel, M. H. Prins, D. B. van der Schaaf, M. E. Durieux, and D. Strumper
Perioperative Blood Transfusions and Delayed Wound Healing After Hip Replacement Surgery: Effects on Duration of Hospitalization
Anesth. Analg., May 1, 2005; 100(5): 1416 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
K. Karkouti, S. A. McCluskey, L. Evans, N. Mahomed, M. Ghannam, and R. Davey
Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery: [Le traitement a l'erythropoietine reduit efficacement les transfusions de culots globulaires en chirurgie orthopedique]
Can J Anesth, April 1, 2005; 52(4): 362 - 368.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. Ogonda, R. Wilson, P. Archbold, M. Lawlor, P. Humphreys, S. O'Brien, and D. Beverland
A Minimal-Incision Technique in Total Hip Arthroplasty Does Not Improve Early Postoperative Outcomes. A Prospective, Randomized, Controlled Trial
J. Bone Joint Surg. Am., April 1, 2005; 87(4): 701 - 710.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
N. Rosencher, D. Poisson, A. Albi, M. Aperce, J. Barre, and C. M. Samama
Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery: [Deux injections d'erythropoietine corrigent une anemie moderee chez la plupart des patients en attente d'une operation orthopedique]
Can J Anesth, February 1, 2005; 52(2): 160 - 165.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. L. Pierson, T. J. Hannon, and D. R. Earles
A Blood-Conservation Algorithm to Reduce Blood Transfusions After Total Hip and Knee Arthroplasty
J. Bone Joint Surg. Am., July 1, 2004; 86(7): 1512 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. Couvret, M. Laffon, A. Baud, V. Payen, P. Burdin, and J. Fusciardi
A Restrictive Use of Both Autologous Donation and Recombinant Human Erythropoietin Is an Efficient Policy for Primary Total Hip or Knee Arthroplasty
Anesth. Analg., July 1, 2004; 99(1): 262 - 271.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
E. Pola, P. Papaleo, A. Santoliquido, G. Gasparini, L. Aulisa, and E. De Santis
Clinical Factors Associated with an Increased Risk of Perioperative Blood Transfusion in Nonanemic Patients Undergoing Total Hip Arthroplasty
J. Bone Joint Surg. Am., January 1, 2004; 86(1): 57 - 61.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. Zarin, D. Grosvenor, D. Schurman, and S. Goodman
Efficacy of Intraoperative Blood Collection and Reinfusion in Revision Total Hip Arthroplasty
J. Bone Joint Surg. Am., November 1, 2003; 85(11): 2147 - 2151.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. L. L. Movig, M. W. H. E. Janssen, J. de Waal Malefijt, P. J. Kabel, H. G. M. Leufkens, and A. C. G. Egberts
Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients
Arch Intern Med, October 27, 2003; 163(19): 2354 - 2358.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
H. P. Bezwada, D. G. Nazarian, D. H. Henry, and R. E. Booth Jr.
Preoperative Use of Recombinant Human Erythropoietin Before Total Joint Arthroplasty
J. Bone Joint Surg. Am., September 1, 2003; 85(9): 1795 - 1800.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
C. Howe, C. Paschall, A. Panwalkar, J. Beal, and A. Potti
A Model for Clinical Estimation of Perioperative Hemorrhage
Clinical and Applied Thrombosis/Hemostasis, April 1, 2003; 9(2): 131 - 135.
[Abstract] [PDF]


Home page
J Am Acad Orthop SurgHome page
E. M. Keating and J. B. Meding
Perioperative Blood Management Practices in Elective Orthopaedic Surgery
J. Am. Acad. Ortho. Surg., November 1, 2002; 10(6): 393 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
S. Jari and K. D. Shelbourne
Simultaneous Bilateral Anterior Cruciate Ligament Reconstruction
Am. J. Sports Med., November 1, 2002; 30(6): 891 - 895.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
D. B. Billote, S. N. Glisson, D. Green, and R. L. Wixson
A Prospective, Randomized Study of Preoperative Autologous Donation for Hip Replacement Surgery
J. Bone Joint Surg. Am., August 12, 2002; 84(8): 1299 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. Couvret, S. Tricoche, A. Baud, B. Dabo, S. Buchet, M. Palud, and J. Fusciardi
The Reduction of Preoperative Autologous Blood Donation for Primary Total Hip or Knee Arthroplasty: The Effect on Subsequent Transfusion Rates
Anesth. Analg., April 1, 2002; 94(4): 815 - 823.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. A. Salido, L. A. Marin, L. A. Gomez, P. Zorrilla, and C. Martinez
Preoperative Hemoglobin Levels and the Need for Transfusion After Prosthetic Hip and Knee Surgery : Analysis of Predictive Factors
J. Bone Joint Surg. Am., February 1, 2002; 84(2): 216 - 220.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
W. A. van Klei, K. G. M. Moons, A. T. Rheineck Leyssius, J. T. A. Knape, C. L. G. Rutten, and D. E. Grobbee
A reduction in Type and Screen: preoperative prediction of RBC transfusions in surgery procedures with intermediate transfusion risks
Br. J. Anaesth., August 1, 2001; 87(2): 250 - 257.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
S. I. Hakki, J. Fareed, D. A. Hoppensteadt, H. Abdullah, J. Camblin, A. F. Nasseri, O. Hamadeh, and T. Wright
Plasma Tissue Factor Pathway Inhibitor Levels as a Marker for Postoperative Bleeding After Enoxaparin Use in Deep Vein Thrombosis Prophylaxis in Orthopedics and General Surgery
Clinical and Applied Thrombosis/Hemostasis, January 1, 2001; 7(1): 65 - 71.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
S. I. Hakki, J. Fareed, D. A. Hoppensteadt, H. Abdullah, J. Camblin, A. F. Nasseri, O. Hamadeh, and T. Wright
Plasma Tissue Factor Pathway Inhibitor Levels as a Marker for Postoperative Bleeding After Enoxaparin Use in Deep Vein Thrombosis Prophylaxis in Orthopedics and General Surgery
Clinical and Applied Thrombosis/Hemostasis, October 1, 2000; 6(4): 206 - 212.
[Abstract] [PDF]


Home page
JBJSHome page
D. Grosvenor, V. Goyal, and S. Goodman
Efficacy of Postoperative Blood Salvage Following Total Hip Arthroplasty in Patients with and without Deposited Autologous Units
J. Bone Joint Surg. Am., July 1, 2000; 82(7): 951 - 951.
[Abstract] [Full Text]


Home page
JBJSHome page
J. M. Murkin, G. M. Haig, K. J. Beer, J. McCutchen, M. E. Comunale, R. Hall, and B. B. Ruzicka
Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement
J. Bone Joint Surg. Am., May 1, 2000; 82(5): 675 - 675.
[Abstract] [Full Text]


Home page
JBJSHome page
A. M. HATZIDAKIS, M. R. MENDLICK, T. McKILLIP, R. L. REDDY, and K. L. GARVIN
Preoperative Autologous Donation for Total Joint Arthroplasty. An Analysis of Risk Factors for Allogenic Transfusion
J. Bone Joint Surg. Am., January 1, 2000; 82(1): 89 - 100.
[Abstract] [Full Text]